z-logo
open-access-imgOpen Access
Intrapartum Antibiotic Chemoprophylaxis Policies for the Prevention of Group B Streptococcal Disease Worldwide: Systematic Review
Author(s) -
Kirsty Le Doaré,
Megan O’Driscoll,
Kim Turner,
Farah Seedat,
Neal Russell,
Anna C. Seale,
Paul T. Heath,
Joy E. Lawn,
Carol J. Baker,
Linda Bartlett,
Clare Cutland,
Michael G. Gravett,
Margaret Ip,
Shabir A. Madhi,
Craig E. Rubens,
Samir K. Saha,
Stephanie J. Schrag,
Ajoke Sobanjo-ter Meulen,
Johan Vekemans,
Beate Kampmann,
A Ramoni,
Rikke Bek Helmig,
Kaarin Mäkikallio,
Tengiz Asatiani,
M. Bruce Fisher,
Michael Feinstein,
Yuval Oz,
Matan Elami Suzin,
Vered H. Eisenberg,
Alberto Berardi,
Indi Trehan,
Georgia Leigh Macad,
Miha Lučovnik,
Claire Oluwalana,
Pippa Letchworth,
Martin Jagoutz-Herzlinger,
Francis G. Muriithi,
Kouther Issa Yassen,
Gerard H.A. Visser,
Sophie Cooper
Publication year - 2017
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cix654
Subject(s) - medicine , chemoprophylaxis , medline , family medicine , disease , systematic review , antibiotic prophylaxis , environmental health , pediatrics , antibiotics , microbiology and biotechnology , political science , law , biology
Intrapartum antibiotic chemoprophylaxis (IAP) prevents most early-onset group B streptococcal (GBS) disease. However, there is no description of how IAP is used around the world. This article is the sixth in a series estimating the burden of GBS disease. Here we aimed to review GBS screening policies and IAP implementation worldwide.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom